SCHEMBL28655707

SCHEMBL28655707

O=C(O)c1ccc(-n2nnnc2SCC(O)N2CCc3cc(N4CCOCC4)ccc32)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.51
▸ SMN1; SMN2 Q16637 1/20 0.51
▸ TSHR P16473 2/20 0.48
▸ KMT2A Q03164 7/20 0.47
▸ MEN1 O00255 6/20 0.47
▸ LMNA P02545 4/20 0.47
▸ APOBEC3A P31941 2/20 0.47
▸ APOBEC3G Q9HC16 2/20 0.47
▸ MAPT P10636 3/20 0.46
▸ HTT P42858 1/20 0.46
▸ CLK1 P49759 1/20 0.46
▸ HPGD P15428 2/20 0.44
▸ MAPK1 P28482 1/20 0.41
▸ PPARG P37231 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ CYP1A2 P05177 1/20 0.41
▸ CYP3A4 P08684 1/20 0.41
▸ CYP2D6 P10635 1/20 0.41
▸ CYP2C9 P11712 1/20 0.41
▸ CYP2C19 P33261 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28659024 0.86 ALDH1A1 (0.48) ALDH1A1SMN1; SMN2TSHRKMT2AMEN1
SCHEMBL28673832 0.86 MEN1 (0.53) ALDH1A1SMN1; SMN2TSHRKMT2AMEN1
SCHEMBL28669727 0.86 MEN1 (0.48) ALDH1A1SMN1; SMN2TSHRKMT2AMEN1
SCHEMBL28660616 0.85 HPGD (0.46) ALDH1A1SMN1; SMN2TSHRKMT2AMEN1
SCHEMBL28664789 0.84 HPGD (0.45) ALDH1A1SMN1; SMN2TSHRKMT2AMEN1
SCHEMBL21952024 0.83 TSHR (0.61) ALDH1A1SMN1; SMN2TSHRKMT2AMEN1
SCHEMBL21952043 0.76 ALDH1A1 (0.64) ALDH1A1SMN1; SMN2TSHRKMT2AMEN1
SCHEMBL28929896 0.76 ALDH1A1 (0.53) ALDH1A1SMN1; SMN2TSHRKMT2AMEN1
SCHEMBL25610429 0.76 TSHR (0.58) ALDH1A1SMN1; SMN2TSHRKMT2AMEN1
SCHEMBL28661287 0.73 ALDH1A1 (0.47) ALDH1A1SMN1; SMN2TSHRKMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115768422-A Ubiquitin ligase inhibitors for the treatment of cancer 诺沃亚桑托斯教授基金会 2023-03-07 — — CN disclosed
CN-113677340-A Compounds that selectively and efficiently inhibit Hakai-mediated ubiquitination as anti-cancer agents 诺沃亚桑托斯教授基金会 2021-11-19 — — CN disclosed
Send feedback